$AIM SURGING 🚀 +24% PREMARKET! 🔹 AIM ImmunoTech is a biotech developing Ampligen for cancers, viral diseases, and immune-related conditions 🧬 🔹 Latest catal

Breakout Stocks • 2026-06-04 10:01 UTC • By Billy Odell Tucker-Robinson

$AIM SURGING 🚀 +24% PREMARKET! 🔹 AIM ImmunoTech is a biotech developing Ampligen for cancers, viral diseases, and immune-related conditions 🧬 🔹 Latest catalyst: Phase 2 DURIPANC enrollment completed ahead of schedule in metastatic pancreatic cancer 🔥 🔹 Trial is studying Ampligen with AstraZene…

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly